Reference health
Impaired <scp>l</scp>-arginine-nitric oxide pathway contributes to the pathogenesis of resistant hypertension
57/57 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 57 checked references that resolve
resolves10.1161/CIRCULATIONAHA.108.189141
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
resolves10.1038/jhh.2013.77
Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes
resolves10.1097/HJH.0b013e328353634e
Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs
resolves10.2337/db09-1772
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy
resolves10.1097/HJH.0b013e3283487806
In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome
resolves10.1161/HYPERTENSIONAHA.118.12358
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease
resolves10.1097/HJH.0b013e32833992ef
Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells
resolves10.1161/HYPERTENSIONAHA.118.11071
Specific Afferent Renal Denervation Prevents Reduction in Neuronal Nitric Oxide Synthase Within the Paraventricular Nucleus in Rats With Chronic Heart Failure
resolves10.1186/s13063-017-2343-3
Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
resolves10.1111/apha.12344
Augmented endothelial‐specific <scp>L</scp>‐arginine transport prevents obesity‐induced hypertension
resolves10.1161/CIRCRESAHA.113.301577
The Identification of Nitric Oxide as Endothelium-Derived Relaxing Factor
resolves10.1016/S0014-2999(00)00647-6
Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro
resolves10.1097/CCM.0b013e318206c1fb
The impact of intrarenal nitric oxide synthase inhibition on renal blood flow and function in mild and severe hyperdynamic sepsis*
resolves10.1152/ajprenal.00084.2011
Evidence that renal arginine transport is impaired in spontaneously hypertensive rats
resolves10.1111/j.1748-1716.2011.02330.x
Role of <scp>l</scp>‐arginine uptake mechanisms in renal blood flow responses to angiotensin II in rats
resolves10.1111/j.1751-7176.2012.00690.x
Prevalence and Correlates of Low Medication Adherence in Apparent Treatment‐Resistant Hypertension
resolves10.1016/S0140-6736(15)00418-3
The double challenge of resistant hypertension and chronic kidney disease
resolves10.1016/j.pharmthera.2007.08.001
l-Arginine transporters in cardiovascular disease: A novel therapeutic target
resolves10.1111/j.1440-1681.2008.05123.x
ROLE OF <scp>l</scp>‐ARGININE IN NITRIC OXIDE PRODUCTION IN HEALTH AND HYPERTENSION
resolves10.1007/s11906-015-0570-0
The Role of Central Nervous System Mechanisms in Resistant Hypertension
resolves10.1161/hyp.38.4.896
Overexpression of eNOS in the RVLM Causes Hypotension and Bradycardia Via GABA Release
resolves10.1161/hy0202.102701
Cardiovascular Effects of Overexpression of Endothelial Nitric Oxide Synthase in the Rostral Ventrolateral Medulla in Stroke-Prone Spontaneously Hypertensive Rats
resolves10.1161/01.HYP.0000050649.30821.CB
Overexpression of eNOS in RVLM Improves Impaired Baroreflex Control of Heart Rate in SHRSP
resolves10.1113/jphysiol.2004.075747
Exogenous nitric oxide inhibits sympathetically mediated vasoconstriction in human skin
resolves10.1152/ajpregu.00477.2004
Angiotensin II and nitric oxide in neural control of intrarenal blood flow
resolves10.31083/j.rcm.2019.01.51
Renal nerve ablation for resistant hypertension: facts, fictions and future directions
resolves10.1016/j.jash.2014.03.180
Carotid stiffness and endothelial function after renal sympathetic denervation in patients with resistant hypertension
resolves10.3109/08037051.2014.940710
Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers
resolves10.3109/10641963.2011.618203
The Relationship between Resistant Hypertension and Arterial Stiffness
resolves10.2147/CIA.S68544
Relationship between resistant hypertension and&nbsp;arterial stiffness assessed&nbsp;by brachial-ankle pulse wave velocity in the older patient
resolves10.1161/HYPERTENSIONAHA.118.12367
Prognostic Impact of Aortic Stiffness in Patients With Resistant Hypertension
resolves10.1161/HYPERTENSIONAHA.109.142190
Arterial Stiffness Is Regulated by Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor During Changes in Blood Flow in Humans
resolves10.1074/jbc.M309552200
Tumor Necrosis Factor-α Inhibits Endothelial Nitric-oxide Synthase Gene Promoter Activity in Bovine Aortic Endothelial Cells
resolves10.1016/j.yjmcc.2007.08.015
C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling
resolves10.1161/01.CIR.0000033116.22237.F9
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells
resolves10.1155/2015/631594
Vascular Damage in Resistant Hypertension: TNF-Alpha Inhibition Effects on Endothelial Cells
resolves10.1016/j.ajhg.2012.03.018
Nitric-Oxide Supplementation for Treatment of Long-Term Complications in Argininosuccinic Aciduria
resolves10.1161/HYPERTENSIONAHA.109.147686
Clinical Potential of Combined Organic Nitrate and Phosphodiesterase Type 5 Inhibitor in Treatment-Resistant Hypertension
resolves10.1126/science.1079368
Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide
resolves10.1016/j.freeradbiomed.2014.05.016
Regulation of obesity and insulin resistance by nitric oxide
resolves10.1161/CIRCRESAHA.112.266395
Overexpression of Endothelial Nitric Oxide Synthase Prevents Diet-Induced Obesity and Regulates Adipocyte Phenotype
resolves10.2337/db07-1623
Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes
The 2 references without a DOI — listed, not checked
no DOI — not checkedRenal denervation for resistant hypertension
no DOI — not checkedPhenotypic characteristics of resistant hypertension in the Brazilian population
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1042/cs20190851"><img src="https://citestamp.com/citestamped/10.1042/cs20190851/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1042/cs20190851)